98,600 Shares in SPDR S&P Biotech ETF $XBI Bought by Keystone Investors PTE Ltd.

Keystone Investors PTE Ltd. bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 98,600 shares of the exchange traded fund’s stock, valued at approximately $12,022,000. SPDR S&P Biotech ETF comprises approximately 1.1% of Keystone Investors PTE Ltd.’s investment portfolio, making the stock its 22nd largest holding.

Other institutional investors have also recently made changes to their positions in the company. Dynamic Wealth Strategies LLC boosted its position in SPDR S&P Biotech ETF by 3.8% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after acquiring an additional 80 shares during the last quarter. Capital Investment Advisory Services LLC boosted its position in SPDR S&P Biotech ETF by 4.0% during the fourth quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock worth $259,000 after acquiring an additional 81 shares during the last quarter. Compass Ion Advisors LLC boosted its position in SPDR S&P Biotech ETF by 2.6% during the fourth quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock worth $474,000 after acquiring an additional 97 shares during the last quarter. Moors & Cabot Inc. boosted its position in SPDR S&P Biotech ETF by 3.8% during the third quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock worth $272,000 after acquiring an additional 100 shares during the last quarter. Finally, Kingsview Wealth Management LLC boosted its position in SPDR S&P Biotech ETF by 1.8% during the third quarter. Kingsview Wealth Management LLC now owns 5,813 shares of the exchange traded fund’s stock worth $582,000 after acquiring an additional 103 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 0.8%

XBI opened at $133.79 on Friday. The firm has a market capitalization of $8.54 billion, a PE ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a twelve month low of $80.90 and a twelve month high of $139.19. The firm’s 50-day moving average price is $132.63 and its 200 day moving average price is $127.12.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.